Skip to main content

BioScrip Value Stock - Dividend - Research Selection

BioScrip

ISIN: US09069N1081, WKN: A0DQLD

Market price date: 30.10.2020
Market price: 13,33 USD




BioScrip Fundamental data and company key figures of the share

Annual reports in USD
Key figures 13-03-2020
Cash flow
Net operating cash flow 39.467.000
Capital Expenditures -28.292.000
Free cash flow 11.175.000
Balance sheet
Total Equity 906.827.000
Liabilities & Shareholders equity 2.589.550.000
Income statement
Net income -75.920.000
Eps (diluted) -1,960
Diluted shares outstanding 38.734.800
Net sales/revenue 2.310.420.000

Fundamental ratios calculated on: 30-10-2020

Ratios
Key figures 30-10-2020
Cash flow
P/C 13,08
   
P/FC 46,20
Balance sheet
ROI-2,93
ROE35,02
Income statement
P/E-6,80
Div. Yield0,00%
P/B0,57
P/S0,22


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolBIOS
Market Capitalization516.334.880,00 USD
CountryUnited States
IndicesNO INDEX
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split2020-02-03,1.000000/4.000000
Internetwww.bioscrip.com


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.bioscrip.com